Immunome IMNM Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's deferred tax assets and other non-current assets?
- Immunome (IMNM) reported deferred tax assets and other non-current assets of $5.36M in Q1 2026.
- How has Immunome's deferred tax assets and other non-current assets changed year-over-year?
- Immunome's deferred tax assets and other non-current assets increased by 23.4% year-over-year, from $4.35M to $5.36M.
- What is the long-term trend for Immunome's deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), Immunome's deferred tax assets and other non-current assets has grown at a 577.3% compound annual growth rate (CAGR), from $100K to $4.59M.